Alessandro Sanitin/LinkedIn
Apr 7, 2026, 13:50
Alessandro Santin Discusses New Targets in Rare Endometrial Disease – Yale Obstetrics, Gynecology and Reproductive Sciences
Yale Obstetrics, Gynecology and Reproductive Sciences shared a post on LinkedIn:
” ‘It’s only when you acquire the type of deep knowledge in the molecular characteristic that you may really identify potential targets,’ says our own Yale Ob/Gyn’s Alessandro Sanitin, MD.
In an interview with Contemporary OB/GYN, Dr. Santin discusses his investigation of new treatments for rare endometrial disease.
Read and/or listen here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 7, 2026, 16:48SOGC Raises Concerns Over Bill S-228 and Reproductive Care Access
-
Apr 7, 2026, 16:43Sonia Gayete-Lafuente Shares Insights on Lactation Without Pregnancy – Center for Human Reproduction
-
Apr 7, 2026, 16:34Shruthi Mahalingaiah: Many Patients Want to Know What Happens to Irregular Cycles Over Time
-
Apr 7, 2026, 16:27The Countdown to Immunology 2026 Is On! – The American Association of Immunologists
-
Apr 7, 2026, 14:20Uncovering the Role of the Immune System in Endometriosis – Science Magazine
-
Apr 7, 2026, 14:08Registrations Open for France’s National Birth Centers Congress – ANSFL Association
-
Apr 7, 2026, 13:57This Month’s Fertility and Sterility Unplugged Episode Is Out Now
-
Apr 7, 2026, 13:15Joel Naftalin and Tina Tellum Discuss Adenomyosis Ultrasound in ISUOG Podcast – ISUOG
-
Apr 7, 2026, 10:26Ane Gerda Zahl Eriksson to Lead ESGO Meet the Surgeon Webinar – ESGO